Gradient nanofibrous chitosan/poly e{open}-caprolactone scaffolds as extracellular microenvironments for vascular tissue engineering

Biomaterials

Volumn 33, Issue 3, 2012, Pages 762-770

  Du, Fengyi ^a   Wang, Hao ^a   Zhao, Wei ^a   Li, Dong ^a   Kong, Deling ^a   Yang, Jun ^a   Zhang, Yuanyuan ^b  

^a NANKAI UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulation; Endothelialization; Heparin; Scaffolds; Vascular cells; VEGF

Indexed keywords

ANTI-COAGULATION; ENDOTHELIALIZATION; HEPARIN; VASCULAR CELLS; VEGF;

ADHESION; BLOOD; BLOOD VESSELS; CHITOSAN; ENDOTHELIAL CELLS; ENZYME ACTIVITY; GRAFTS; MAMMALS; MONOLAYERS; NANOFIBERS; POLYSACCHARIDES; SCAFFOLDS; TISSUE;

SCAFFOLDS (BIOLOGY);

CHITOSAN; NANOFIBER; POLYCAPROLACTONE; TISSUE SCAFFOLD; VASCULOTROPIN;

ADVENTITIA; ANTICOAGULATION; ARTICLE; BLOOD VESSEL GRAFT; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; ELECTROSPINNING; ENDOTHELIUM CELL; HEPARINIZATION; HUMAN; HUMAN CELL; MICROENVIRONMENT; MONOLAYER CULTURE; NANOFABRICATION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; THROMBOCYTE ADHESION; THROMBOSIS; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASCULAR TISSUE;

CHITOSAN; HEPARIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; POLYESTERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MAMMALIA;

EID: 81155150287     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.10.037     Document Type: Article

References (32)

1. Leon L., Greisler H.P. Vascular grafts. Expert Rev Cardiovasc Ther 2003, 1:581.
2. Heydarkhan-Hagvall S., Esguerra M., Helenius G., Söderberg R., Johansson B.R., Risberg B. Production of extracellular matrix components in tissue-engineered blood vessels. Tissue Eng 2006, 12:831.
3. Wang X., Wenk E., Zhang X., Meinel L., Vunjak-Novakovic G., Kaplan D.L. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 2009, 134(2):81-90.
4. DeLong S.A., Moon J.J., West J.L. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 2005, 26(16):3227-3234.
5. Kang C.E., Gemeinhart E.J., Gemeinhart R.A. Cellular alignment by grafted adhesion peptide surface density gradients. J Biomed Mater Res A 2004, 71(3):403-411.
6. Rosoff W.J., Urbach J.S., Esrick M.A., McAllister R.G., Richards L.J., Goodhill G.J. A new chemotaxis assay shows the extreme sensitivity of axons to molecular gradients. Nat Neurosci 2004, 7(6):678-682.
7. Chung Y.I., Kim S.K., Lee Y.K., Park S.J., Cho K.O., Yuk S.H., et al. Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex. J Control Release 2010, 143(3):282-289.
8. Jeon O., Ryu S.H., Chung J.H., Kim B.S. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release 2005, 105(3):249-259.
9. Ho Y.C., Mi F.L., Sung H.W., Kuo P.L. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor. Int J Pharm 2009, 376(1-2):69-75.
10. Joung Y.K., Bae J.W., Park K.D. Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration. Expert Opin Drug Deliv 2008, 5(11):1173-1184.
11. Reilly C.F., Kindy M.S., Brown K.E., Rosenberg R.D., Sonenshein G.E. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem 1989, 264(12):6990-6995.
12. Teomim D., Fishbien I., Golomb G., Orloff L., Mayberg M., Domb A.J. Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury. J Control Release 1999, 60(1):129-142.
13. He W., Ma Z., Teo W.E., Dong Y.X., Robless P.A., Lim T.C., et al. Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts. J Biomed Mater Res A 2009, 90(1):205-216.
14. Hashi C.K., Zhu Y., Yang G.Y., Young W.L., Hsiao B.S., Wang K. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci 2007, 104(29):11915-11920.
15. Alvarez-Perez M.A., Guarino V., Cirillo V., Ambrosio L. Influence of gelatin cues in PCL electrospun membranes on nerve outgrowth. Biomacromolecules 2010, 11(9):2238-2246.
16. Hiep N.T., Lee B.T. Electro-spinning of PLGA/PCL blends for tissue engineering and their biocompatibility. J Mater Sci Mater Med 2010, 21(6):1969-1978.
17. Chong E.J., Phan T.T., Lim I.J., Zhang Y.Z., Bay B.H., Ramakrishna S., et al. Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution. Acta Biomater 2007, 3(3):321-330.
18. Chen Z.G., Wang P.W., Wei B., Mo X.M., Cui F.Z. Electrospun collagen-chitosan nanofiber: a biomimetic extracellular matrix for endothelial cell and smooth muscle cell. Acta Biomater 2010, 6(2):372-382.
19. Prabhakaran M.P., Venugopal J.R., Chyan T.T., Hai L.B., Chan C.K., Lim A.Y., et al. Electrospun biocomposite nanofibrous scaffolds for neural tissue engineering. Tissue Eng Part A 2008, 14(11):1787-1797.
20. Feng Z.Q., Chu X., Huang N.P., Wang T., Wang Y., Shi X., et al. The effect of nanofibrous galactosylated chitosan scaffolds on the formation of rat primary hepatocyte aggregates and the maintenance of liver function. Biomaterials 2009, 30(14):2753-2763.
21. Rousseau S., Houle F., Huot J. Integrating the VEGF signals leading to actin-based Motility in vascular endothelial cells. Trends Cardiovas Med 2000, 10(8):321-327.
22. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. Faseb J 2003, 17(15):2260-2262.
23. Pike D.B., Cai S., Pomraning K.R., Firpo M.A., Fisher R.J., Shu X.Z., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006, 27(30):5242-5251.
24. Hinrichs W.L., Ten Hoopen H.W., Engbers G.H., Feijen J. In vitro evaluation of heparinized cuprophan hemodialysis membranes. J Biomed Mater Res 1997, 35(4):443-450.
25. Lee S.J., Liu J., Oh S.H., Soker S., Atala A., Yoo J.J. Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials 2008, 29(19):2891-2898.
26. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005, 23(1):47-55.
27. Zhang J., Skardal A., Prestwich G.D. Engineered extracellular matrices with cleavable crosslinkers for cell expansion and easy cell recovery. Biomaterials 2008, 29(34):4521-4531.
28. Kraehenbuehl T.P., Zammaretti P., Van der Vlies A.J., Schoenmakers R.G., Lutolf M.P., Jaconi M.E., et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials 2008, 29(18):2757-2766.
29. Zhou M., Liu Z., Wei Z., Liu C., Qiao T., Ran F., et al. Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor. Artif Organs 2009, 33(3):230-239.
30. L'Heureux N., Dusserre N., Konig G., Victor B., Keire P., Wight T.N., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006, 12(3):361-365.
31. Chiu L.L., Radisic M. Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials 2010, 31(2):226-241.
32. Zhang X., Thomas V., Xu Y., Bellis S.L., Vohra Y.K. An in vitro regenerated functional human endothelium on a nanofibrous electrospun scaffold. Biomaterials 2010, 31(15):4376-4381.